Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ASND | INCY |
|---|---|---|
| Price | $227.45 | $118.78 |
| Change today | ▼ 0.17% | ▼ 2.12% |
| Market cap | $14.97B | $24.08B |
| Return, 3 months | -15.1% | +4.4% |
| Return, year to date | +6.7% | +20.3% |
| Return, 1 year | +18.5% | +37.0% |
| P/E (TTM) | 17.9 | 15.1 |
| P/B | 9.2 | 3.8 |
| P/E percentile vs own 5y | 92nd | 7th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +114.7% | +37.7% |
| Net profit growth (YoY) | +632.7% | +44.6% |
| Gross margin | 91.3% | 92.6% |
| Operating margin | 25.1% | 31.6% |
| Net margin | 70.8% | 27.7% |
| Return on equity | 118.8% | 30.7% |
| Analyst target vs. price | +39.6% | +18.4% |
| Analyst buy share | 100% | 79% |
| RSI (14) | 38 | 44 |
| 30-day volatility | 47.9% | 26.3% |
| Max drawdown, 1 year | -19.5% | -18.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
